Vitamin A supplements, routine immunization, and the subsequent risk of Plasmodium infection among children under 5 years in sub-Saharan Africa

Maria-Graciela Hollm-Delgado, Frédéric B. Piel, Daniel J. Weiss, Rosalind E. Howes, Elizabeth A. Stuart, Simon I Hay, Robert E. BlackeLife 2015 · DOI

TL;DR

This study investigated whether vitamin A supplementation and routine childhood vaccinations affect malaria risk in sub-Saharan African children. While most standard vaccines showed no impact, vitamin A supplementation was found to significantly reduce the risk of malaria infection (both parasitemia and antigenemia). Interestingly, BCG vaccination was associated with an increased risk of malaria antigenemia, suggesting a complex interplay between vaccines and parasitic infections.

What Problem Does This Paper Address?

Malaria remains a devastating disease, particularly for children under five in sub-Saharan Africa, where immunization coverage is high. While some research, particularly in animal models, suggested that childhood immunizations and vitamin A supplementation might offer non-specific protection against malaria, robust evidence in humans was lacking. This study aimed to fill that gap by examining the association between these interventions and malaria infection in a large, real-world population.

Methods

The researchers analyzed data from national Demographic and Health Surveys (DHS) conducted in four sub-Saharan African countries (Burkina Faso, Mozambique, Rwanda, and Senegal). They used a large dataset of children aged 6-59 months, collecting information on their vaccination history (BCG, DTP, measles, polio) and vitamin A supplementation, alongside malaria status determined by blood films (for Plasmodium spp. parasitemia) and rapid diagnostic tests for Plasmodium falciparum histidine-rich protein-2 (PfHRP-2) antigenemia.

To account for potential confounding factors and biases inherent in observational studies, they employed inverse probability weighting (IPW) models. This technique uses propensity scores to balance characteristics between groups receiving and not receiving the interventions, mimicking some aspects of a randomized controlled trial. They also performed sensitivity analyses to assess the robustness of their findings.

Datasets

The primary dataset used was extracted from Macro International Demographic and Health Surveys (DHS) conducted between May 2010 and November 2011 in Burkina Faso, Mozambique, Rwanda, and Senegal. This dataset included information on children's vaccination status, vitamin A supplementation, and malaria testing results.

Additional data on malaria seasonality was derived from moderate resolution imaging spectroradiometer (MODIS) bidirectional reflectance distribution function (BRDF)-corrected composites (MCD43B4) to estimate enhanced vegetation index (EVI). Data on the population prevalence of malaria protective genes (HbS and G6PDd allele frequencies) were also incorporated, sourced from global predicted surface maps.

Key Insights and Ideas

  • Vitamin A as a Protective Shield: The most striking finding is the significant protective effect of vitamin A supplementation against malaria infection. This suggests that vitamin A plays a crucial role in bolstering the immune system's ability to combat malaria, even in the presence of high vaccination rates.
  • BCG's Unexpected Association: The association between BCG vaccination and an increased risk of malaria antigenemia is counterintuitive and warrants further investigation. The authors hypothesize this might be due to the tests inadvertently detecting other parasitic infections that can mimic malaria antigenemia, or a complex immune interaction.
  • Vaccine Specificity: Unlike vitamin A, most standard childhood vaccines (DTP, measles, polio) did not show a significant association with malaria risk in this study, suggesting their primary role is in preventing their target diseases rather than offering broad protection against malaria.
  • Complex Interactions: The study highlights the intricate interplay between nutrition, vaccination, and infectious diseases. Factors like season, age, and even genetic predispositions (like G6PDd allele frequency) can modify the effectiveness of interventions, underscoring the need for nuanced approaches.

Key Results

  • Children receiving vitamin A supplements were significantly less likely to have malaria parasitemia (RR=0.46, 95% CI=0.39–0.54) and antigenemia (RR=0.23, 95% CI=0.17–0.29).
  • Bacille Calmette Guerin (BCG) vaccinated children were more likely to be positive for P. falciparum antigenemia (RR=4.06, 95% CI=2.00–8.28).
  • Measles and polio vaccinations showed no association with malaria.
  • DTP vaccination showed a protective effect on malaria parasitemia and antigenemia, but only in the weighted models.

Limitations and Future Work

The authors acknowledge several limitations:

  • Observational Design: Despite using IPW, the study is observational, meaning residual confounding from unmeasured factors is still possible.
  • Vitamin A History: The study primarily considered the last recorded dose of vitamin A, not a comprehensive history, which could influence the observed effects given vitamin A's storage in the body.
  • EVI as a Proxy for Rainfall: Enhanced Vegetation Index (EVI) is a proxy for rainfall, and there can be temporal lags and variations in its response, potentially complicating interpretation.
  • HIV Status: While adjusted for in some models, the low prevalence of maternal HIV in the study population limited the ability to fully assess potential interactions between vitamin A, HIV, and malaria.

Future research directions suggested include:

  • Randomized Controlled Trials (RCTs): High-quality RCTs are crucial to confirm the efficacy of vitamin A in preventing malaria and to determine optimal dosages and timing of administration relative to other vaccines.
  • Placental Malaria: Further investigation into the role of placental malaria exposure in utero and its interaction with vitamin A's protective effects is warranted.
  • BCG and Antigenemia: More research is needed to understand the mechanism behind the observed association between BCG and increased malaria antigenemia, particularly exploring the possibility of cross-reactivity with other parasitic infections.
  • HIV Interactions: Evaluating the potential interactions between vitamin A, HIV, and malaria infection is important, especially in populations with higher HIV prevalence.

Summary updated

Abstract

Recent studies, partly based on murine models, suggest childhood immunization and vitamin A supplements may confer protection against malaria infection, although strong evidence to support these theories in humans has so far been lacking. We analyzed national survey data from children aged 6-59 months in four sub-Saharan African countries over an 18-month time period, to determine the risk of Plasmodium spp. parasitemia (n=8390) and Plasmodium falciparum HRP-2 (PfHRP-2)-related antigenemia (n=6121) following vitamin A supplementation and standard vaccination. Bacille Calmette Guerin-vaccinated children were more likely to be PfHRP-2 positive (relative risk [RR]=4.06, 95% confidence interval [CI]=2.00-8.28). No association was identified with parasitemia. Measles and polio vaccination were not associated with malaria. Children receiving vitamin A were less likely to present with parasitemia (RR=0.46, 95% CI=0.39-0.54) and antigenemia (RR=0.23, 95% CI=0.17-0.29). Future studies focusing on climate seasonality, placental malaria and HIV are needed to characterize better the association between vitamin A and malaria infection in different settings.
BibTeX
@inproceedings{hollmdelgado2015vitamin,
  author = {Maria-Graciela Hollm-Delgado and Frédéric B. Piel and Daniel J. Weiss and Rosalind E. Howes and Elizabeth A. Stuart and Simon I Hay and Robert E. Black},
  title = {{Vitamin A supplements, routine immunization, and the subsequent risk of Plasmodium infection among children under 5 years in sub-Saharan Africa}},
  booktitle = {eLife},
  year = {2015},
  doi = {10.7554/elife.03925},
}
Figure